Published in Intensive Care Med on December 04, 2007
Comparing USCOM and Echocardiographic Hemodynamic Measurements in Children (CUE Study) | NCT02083172
Hemodynamic Resuscitation and Monitoring in Early Sepsis (HERMES) | NCT04143035
Multiparameter Intelligent Monitoring in Intensive Care II: a public-access intensive care unit database. Crit Care Med (2011) 8.31
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med (2010) 4.64
The impact of early monitored management on survival in hospitalized adult Ugandan patients with severe sepsis: a prospective intervention study*. Crit Care Med (2012) 2.29
Applying dynamic parameters to predict hemodynamic response to volume expansion in spontaneously breathing patients with septic shock. Shock (2013) 2.14
Septic shock and adequacy of early empiric antibiotics in the emergency department. J Emerg Med (2014) 2.09
β-Lactams enhance vancomycin activity against methicillin-resistant Staphylococcus aureus bacteremia compared to vancomycin alone. Antimicrob Agents Chemother (2013) 2.06
Recommendations for sepsis management in resource-limited settings. Intensive Care Med (2012) 2.03
Transfusion of packed red blood cells is not associated with improved central venous oxygen saturation or organ function in patients with septic shock. J Emerg Med (2012) 2.02
Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational study. Crit Care (2012) 2.02
Blood purification and mortality in sepsis: a meta-analysis of randomized trials. Crit Care Med (2013) 1.94
Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults. Thorax (2011) 1.91
Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality. Intensive Care Med (2010) 1.75
Exploring mechanisms of excess mortality with early fluid resuscitation: insights from the FEAST trial. BMC Med (2013) 1.57
Time for a neonatal-specific consensus definition for sepsis. Pediatr Crit Care Med (2014) 1.56
The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med (2013) 1.56
Microcirculatory effects of the transfusion of leukodepleted or non-leukodepleted red blood cells in patients with sepsis: a pilot study. Crit Care (2014) 1.56
Echocardiography practice, training and accreditation in the intensive care: document for the World Interactive Network Focused on Critical Ultrasound (WINFOCUS). Cardiovasc Ultrasound (2008) 1.55
Re-thinking resuscitation: leaving blood pressure cosmetics behind and moving forward to permissive hypotension and a tissue perfusion-based approach. Crit Care (2013) 1.50
Presence of electroencephalogram burst suppression in sedated, critically ill patients is associated with increased mortality. Crit Care Med (2008) 1.48
Impact of timing of renal replacement therapy initiation on outcome of septic acute kidney injury. Crit Care (2011) 1.47
Bench-to-bedside review: the initial hemodynamic resuscitation of the septic patient according to Surviving Sepsis Campaign guidelines--does one size fit all? Crit Care (2008) 1.46
An empirical comparison of key statistical attributes among potential ICU quality indicators. Crit Care Med (2014) 1.43
Sepsis carries a high mortality among hospitalised adults in Malawi in the era of antiretroviral therapy scale-up: a longitudinal cohort study. J Infect (2014) 1.42
Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threatening hypotension. Crit Care (2010) 1.40
Multiplex identification of gram-positive bacteria and resistance determinants directly from positive blood culture broths: evaluation of an automated microarray-based nucleic acid test. PLoS Med (2013) 1.40
Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations. Lung India (2012) 1.40
Role of innate host defenses in susceptibility to early-onset neonatal sepsis. Clin Perinatol (2010) 1.39
The pursuit of a high central venous oxygen saturation in sepsis: growing concerns. Crit Care (2008) 1.33
Epidemiology of acute kidney injury in the intensive care unit. Crit Care Res Pract (2013) 1.32
The harmful role of c5a on innate immunity in sepsis. J Innate Immun (2010) 1.31
Impact of emergency intubation on central venous oxygen saturation in critically ill patients: a multicenter observational study. Crit Care (2009) 1.30
Sepsis-associated encephalopathy. Nat Rev Neurol (2012) 1.30
Molecular diagnosis of sepsis: New aspects and recent developments. Eur J Microbiol Immunol (Bp) (2014) 1.30
Hypoxic hepatitis - epidemiology, pathophysiology and clinical management. Wien Klin Wochenschr (2010) 1.29
Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis. Intensive Care Med (2013) 1.29
Higher vs. lower fluid volume for septic shock: clinical characteristics and outcome in unselected patients in a prospective, multicenter cohort. Crit Care (2012) 1.28
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria. Crit Care (2014) 1.25
Elevated plasma levels of heparin-binding protein in intensive care unit patients with severe sepsis and septic shock. Crit Care (2012) 1.23
Hydroxyethylstarch impairs renal function and induces interstitial proliferation, macrophage infiltration and tubular damage in an isolated renal perfusion model. Crit Care (2009) 1.23
The international PROGRESS registry of patients with severe sepsis: drotrecogin alfa (activated) use and patient outcomes. Crit Care (2009) 1.22
Sepsis-induced cardiomyopathy. Curr Cardiol Rev (2011) 1.21
Guidelines for end-of-life and palliative care in Indian intensive care units' ISCCM consensus Ethical Position Statement. Indian J Crit Care Med (2012) 1.19
Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients. Antimicrob Agents Chemother (2009) 1.17
Pathophysiology and treatment of septic shock in neonates. Clin Perinatol (2010) 1.17
Biomarkers and molecular analysis to improve bloodstream infection diagnostics in an emergency care unit. PLoS One (2014) 1.17
Bench-to-bedside review: sepsis - from the redox point of view. Crit Care (2011) 1.14
Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients. Crit Care (2010) 1.14
Sedation practice in the intensive care unit: a UK national survey. Crit Care (2008) 1.14
Evaluation of a polymerase chain reaction assay for pathogen detection in septic patients under routine condition: an observational study. PLoS One (2012) 1.12
Factors associated with septic shock and mortality in generalized peritonitis: comparison between community-acquired and postoperative peritonitis. Crit Care (2009) 1.12
Presepsin as a novel sepsis biomarker. World J Emerg Med (2014) 1.12
Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter? Crit Care (2009) 1.11
Health technology assessment review: Computerized glucose regulation in the intensive care unit--how to create artificial control. Crit Care (2009) 1.11
Functional haemodynamic monitoring. Curr Opin Crit Care (2014) 1.11
The availability of clinical protocols in US teaching intensive care units. J Crit Care (2010) 1.10
Hemodynamic variables and progression of acute kidney injury in critically ill patients with severe sepsis: data from the prospective observational FINNAKI study. Crit Care (2013) 1.10
Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes. Crit Care (2012) 1.10
Gender-related outcome difference is related to course of sepsis on mixed ICUs: a prospective, observational clinical study. Crit Care (2011) 1.10
Developing predictive models using electronic medical records: challenges and pitfalls. AMIA Annu Symp Proc (2013) 1.09
Infections with VIM-1 metallo-{beta}-lactamase-producing enterobacter cloacae and their correlation with clinical outcome. J Clin Microbiol (2009) 1.09
Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registry. Crit Care (2010) 1.09
Microcirculatory blood flow as a tool to select ICU patients eligible for fluid therapy. Intensive Care Med (2012) 1.09
Timing and causes of death in septic shock. Ann Intensive Care (2015) 1.09
Severe metabolic or mixed acidemia on intensive care unit admission: incidence, prognosis and administration of buffer therapy. A prospective, multiple-center study. Crit Care (2011) 1.08
Clinical sepsis and septic shock--definition, diagnosis and management principles. Langenbecks Arch Surg (2008) 1.08
Early high protein intake is associated with low mortality and energy overfeeding with high mortality in non-septic mechanically ventilated critically ill patients. Crit Care (2014) 1.06
Antibiotic prescription patterns in the empiric therapy of severe sepsis: combination of antimicrobials with different mechanisms of action reduces mortality. Crit Care (2012) 1.05
Epidemiology of severe sepsis in the emergency department and difficulties in the initial assistance. Clinics (Sao Paulo) (2008) 1.04
Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor. Crit Care (2012) 1.03
Preventable mortality evaluation in the ICU. Crit Care (2012) 1.02
The secondary abdominal compartment syndrome: not just another post-traumatic complication. Can J Surg (2008) 1.02
Safety and efficacy of dexmedetomidine in children with heart failure. Pediatr Cardiol (2012) 1.02
Glycocalyx and sepsis-induced alterations in vascular permeability. Crit Care (2015) 1.01
Persistent Sepsis-Induced Hypotension without Hyperlactatemia: A Distinct Clinical and Physiological Profile within the Spectrum of Septic Shock. Crit Care Res Pract (2012) 1.01
Totem and taboo: fluids in sepsis. Crit Care (2011) 1.00
Hypervolemia induces and potentiates lung damage after recruitment maneuver in a model of sepsis-induced acute lung injury. Crit Care (2010) 1.00
High mortality amongst adolescents and adults with bacterial meningitis in sub-Saharan Africa: an analysis of 715 cases from Malawi. PLoS One (2013) 0.99
Lactate as a hemodynamic marker in the critically ill. Curr Opin Crit Care (2012) 0.99
Small nerve fiber pathology in critical illness. PLoS One (2013) 0.97
The significance of non-sustained hypotension in emergency department patients with sepsis. Intensive Care Med (2009) 0.97
Tight perioperative glycemic control using an artificial endocrine pancreas. Surg Today (2009) 0.97
Sepsis-associated acute kidney injury. Semin Nephrol (2015) 0.96
The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial. Crit Care (2013) 0.96
Treatment of Fournier's Gangrene with Combination of Vacuum-Assisted Closure Therapy, Hyperbaric Oxygen Therapy, and Protective Colostomy. Case Rep Anesthesiol (2012) 0.96
Extravascular lung water correlates multiorgan dysfunction syndrome and mortality in sepsis. PLoS One (2010) 0.96
Ventriculo-arterial decoupling in acutely altered hemodynamic states. Crit Care (2013) 0.96
Clinical applicability of functional hemodynamic monitoring. Ann Intensive Care (2011) 0.96
Reducing glycemic variability in intensive care unit patients: a new therapeutic target? J Diabetes Sci Technol (2009) 0.96
Procalcitonin as a marker of Candida species detection by blood culture and polymerase chain reaction in septic patients. BMC Anesthesiol (2014) 0.96
A positive fluid balance is an independent prognostic factor in patients with sepsis. Crit Care (2015) 0.96
The role of vasoactive agents in the resuscitation of microvascular perfusion and tissue oxygenation in critically ill patients. Intensive Care Med (2010) 0.95
Diagnostic value of dynamics serum sCD163, sTREM-1, PCT, and CRP in differentiating sepsis, severity assessment, and prognostic prediction. Mediators Inflamm (2013) 0.94
Prognostic utility of plasma lactate measured between 24 and 48 h after initiation of early goal-directed therapy in the management of sepsis, severe sepsis, and septic shock. J Intensive Care (2016) 0.94
Hypoglycemia in critically ill children. J Diabetes Sci Technol (2012) 0.94
Amebic liver abscess diagnosed by polymerase chain reaction in 14 returning travelers. Am J Trop Med Hyg (2012) 0.94
Is reducing variability of blood glucose the real but hidden target of intensive insulin therapy? Crit Care (2009) 0.93
Controlling coagulation dysregulation in xenotransplantation. Curr Opin Organ Transplant (2011) 0.93
Renal oxygenation in clinical acute kidney injury. Crit Care (2013) 0.92
Fluid management in acute lung injury and ards. Ann Intensive Care (2011) 0.92
Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med (2001) 51.99
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med (2000) 48.03
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med (2001) 46.58
Intensive insulin therapy in critically ill patients. N Engl J Med (2001) 40.00
The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med (2003) 32.30
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med (2003) 28.68
Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med (2001) 27.70
Grading quality of evidence and strength of recommendations. BMJ (2004) 26.08
The acute respiratory distress syndrome. N Engl J Med (2000) 25.38
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med (2004) 24.47
Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med (2005) 23.85
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med (2006) 23.62
Intensive insulin therapy in the medical ICU. N Engl J Med (2006) 22.37
A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med (1999) 20.31
Comparison of two fluid-management strategies in acute lung injury. N Engl J Med (2006) 19.54
Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA (2002) 16.37
International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med (2005) 13.40
A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med (2004) 12.79
Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med (2004) 11.78
Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med (2000) 11.54
Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. Am J Respir Crit Care Med (2002) 10.52
Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med (1998) 10.22
A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med (2003) 10.13
The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis (1983) 10.03
Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med (2007) 10.02
Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med (2006) 9.52
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest (2000) 9.51
Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med (2001) 8.74
Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med (2006) 8.64
Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med (2005) 8.55
Glucose control and mortality in critically ill patients. JAMA (2003) 8.13
Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet (2000) 8.08
Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med (2006) 7.97
Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet (2003) 7.91
A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med (1995) 7.88
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis (2002) 7.81
Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest (2007) 7.49
Transfusion strategies for patients in pediatric intensive care units. N Engl J Med (2007) 7.21
Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ (1992) 7.20
Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med (1994) 7.05
Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc (2004) 7.03
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med (1999) 6.88
Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ (1998) 6.80
Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med (1996) 6.79
Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc (2003) 6.67
Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet (1999) 6.38
A consumer's guide to subgroup analyses. Ann Intern Med (1992) 6.34
Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial. Lancet (2005) 6.33
Concern Daily hemodialysis and the outcome of acute renal failure. N Engl J Med (2002) 5.99
The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest (1998) 5.98
Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA (2001) 5.86
Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology (2006) 5.58
Guidelines for treatment of candidiasis. Clin Infect Dis (2003) 5.55
Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother (2005) 5.35
Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department. Chest (2006) 5.31
An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med (2006) 5.29
Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial. Lancet (2007) 5.23
Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med (1998) 5.22
Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med (1994) 5.19
A high positive end-expiratory pressure, low tidal volume ventilatory strategy improves outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial. Crit Care Med (2006) 5.19
A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med (1998) 4.81
Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet (2007) 4.81
Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest (2006) 4.77
The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med (2002) 4.72
Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep (2002) 4.64
Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol. Crit Care Med (2006) 4.62
Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med (2004) 4.58
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med (2004) 4.56
Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unit. J Hosp Infect (2004) 4.56
Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation (1997) 4.54
Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int (2006) 4.51
The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med (1998) 4.48
Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med (2005) 4.47
Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care Med (2007) 4.42
Double-blind study of selective decontamination of the digestive tract in intensive care. Lancet (1992) 4.33
Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med (2002) 4.33
Cardiac filling pressures are not appropriate to predict hemodynamic response to volume challenge. Crit Care Med (2007) 4.21
Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet (2001) 4.17
Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med (1999) 4.15
Before-after study of a standardized hospital order set for the management of septic shock. Crit Care Med (2006) 4.10
Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA (2002) 4.09
Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery. Arch Dis Child (2001) 3.94
Emergency management of meningococcal disease. Arch Dis Child (1999) 3.93
A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med (1987) 3.89
Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion (2006) 3.86
Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: further evidence for survival and safety and implications for early treatment. Crit Care Med (2005) 3.85
Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med (2005) 3.84
Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest (1989) 3.78
Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med (1995) 3.74
Tidal volume reduction in patients with acute lung injury when plateau pressures are not high. Am J Respir Crit Care Med (2005) 3.69
Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: a randomized controlled trial. JAMA (2003) 3.64
Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization. Am Rev Respir Dis (1992) 3.64
The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med (2006) 3.53
Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials. JAMA (2005) 3.51
Early reversal of pediatric-neonatal septic shock by community physicians is associated with improved outcome. Pediatrics (2003) 3.49
Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology (1996) 3.46
A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int (2001) 3.42
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med (2000) 48.03
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med (2013) 39.56
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med (2003) 28.68
Grading quality of evidence and strength of recommendations. BMJ (2004) 26.08
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med (2004) 24.47
A comprehensive catalogue of somatic mutations from a human cancer genome. Nature (2009) 24.27
Acute respiratory distress syndrome: the Berlin Definition. JAMA (2012) 21.04
Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med (2008) 19.93
Comparison of two fluid-management strategies in acute lung injury. N Engl J Med (2006) 19.54
A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature (2009) 18.39
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med (2013) 17.37
A randomized trial of protocol-based care for early septic shock. N Engl J Med (2014) 16.05
Hydrocortisone therapy for patients with septic shock. N Engl J Med (2008) 15.85
Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med (2008) 14.40
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature (2011) 13.30
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature (2011) 13.18
Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA (2009) 13.00
Sepsis in European intensive care units: results of the SOAP study. Crit Care Med (2006) 11.78
Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med (2004) 11.78
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol (2010) 11.77
International study of the prevalence and outcomes of infection in intensive care units. JAMA (2009) 11.57
Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med (2013) 11.44
Mutational processes molding the genomes of 21 breast cancers. Cell (2012) 11.22
The life history of 21 breast cancers. Cell (2012) 10.59
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med (2003) 10.39
Mortality after surgery in Europe: a 7 day cohort study. Lancet (2012) 9.96
Physician staffing patterns and clinical outcomes in critically ill patients: a systematic review. JAMA (2002) 9.89
Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med (2006) 9.52
RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care (2006) 9.29
Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med (2012) 9.19
Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med (2010) 8.58
Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med (2006) 7.97
Anemia and blood transfusion in critically ill patients. JAMA (2002) 7.83
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis (2002) 7.81
A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med (2008) 7.73
Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study. J Clin Oncol (2007) 7.67
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet (2010) 7.61
Withdrawal of mechanical ventilation in anticipation of death in the intensive care unit. N Engl J Med (2003) 7.32
Trial of the route of early nutritional support in critically ill adults. N Engl J Med (2014) 7.06
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med (2010) 6.69
Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA (2008) 6.29
Part 9: post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation (2010) 6.01
Fever control using external cooling in septic shock: a randomized controlled trial. Am J Respir Crit Care Med (2012) 6.00
National estimates of severe sepsis in United States emergency departments. Crit Care Med (2007) 5.99
Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med (2004) 5.90
Perioperative fluid therapy with tetrastarch and gelatin in cardiac surgery--a prospective sequential analysis*. Crit Care Med (2013) 5.88
Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med (2002) 5.84
Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA (2010) 5.80